Viewing Study NCT04204850


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-01-17 @ 10:45 PM
Study NCT ID: NCT04204850
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2019-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Recurrent Cancer View
None Liver Transplant View
Keywords: